Back to search

Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol

Data up to Jan 2025

Published1977
Citations222
References31

Total Citations Per Year

Abstract

References (31)

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Nonparametric Estimation from Incomplete Observations

1958 • 37,219 citations

A generalized Wilcoxon test for comparing arbitrarily singly-censored samples

1965 • 3,333 citations

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

1975 • 3,051 citations

Treatment for multiple myeloma. Combination chemotherapy with different melphalan dose regimens

1969 • 512 citations

Plasma-Cell Myeloma

1959 • 385 citations

Treatment for Multiple Myeloma

1969 • 377 citations

A generalized two-sample Wilcoxon test for doubly censored data

1965 • 324 citations

Prognostic factors in multiple myeloma

1975 • 235 citations

Kinetics of tumor growth and regression in IgG multiple myeloma

1972 • 217 citations

Combination chemotherapy for multiple myeloma

1972 • 213 citations

Immunoglobulin synthesis and total body tumor cell number in IgG multiple myeloma

1970 • 179 citations

Immunoglobulin synthesis and tumor kinetics of multiple myeloma.

1973 • 153 citations

Growth Rates and Responses to Treatment in Human Myelomatosis

1969 • 116 citations

Expansion of the growth fraction in multiple myeloma with alkylating agents

1975 • 96 citations

Plasma cell myeloma: response of melphalan-resistant patients to high-dose intermittent cyclophosphamide.

1972 • 82 citations

MULTIPLE MYELOMA. II. ANALYSIS OF CYCLOPHOSPHAMIDE THERAPY IN 165 PATIENTS.

1964 • 81 citations

Multiple Myeloma

1964 • 64 citations

Remission Maintenance Therapy for Multiple Myeloma

1975 • 62 citations

Combination chemotherapy of multiple myeloma with Alkeran, Cytoxan, vincristine, prednisone, and BCNU

1974 • 61 citations

Cyclophosphamide vs Melphalan in Treatment of Plasma Cell Myeloma

1969 • 60 citations

VENEREAL DISEASE IN BRITISH WEST AFRICA

1947 • 55 citations

Cellular Kinetics in Multiple Myeloma

1975 • 55 citations

DOXORUBICIN/B.C.N.U. CHEMOTHERAPY FOR MULTIPLE MYELOMA IN RELAPSE

1976 • 53 citations

Treatment of Plasma Cell Myeloma With Cytotoxic Agents

1975 • 50 citations

Effect of chemotherapy on the labelling index of myeloma cells

1974 • 44 citations

Clinical trials with N-isopropyl-α-(2-methylhydrazino)-p-toluamide hydrochloride in malignant lymphoma and other disseminated neoplasia

1967 • 39 citations

Plasma cell myeloma. An interpretive review

1972 • 32 citations

Prognosis of Myelomatosis on Treatment with Prednisone and Cytostatics

1973 • 32 citations

Early recruitment in the human myeloma cell population after cytostatic treatment.

1976 • 15 citations

DNA synthesis in multiple myeloma cells following cell cycle-nonspecific chemotherapy.

1974 • 10 citations

Cited By (0)

No citing papers found in database

Improved survival times in multiple myeloma treated with melphalan, prednisone,… (1977) – The American Journal of Medicine | Metascience Observatory Explorer